Christopher F. Wyatt - Jul 25, 2024 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
SVP & Controller
Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Stock symbol
HCA
Transactions as of
Jul 25, 2024
Transactions value $
-$2,362,020
Form type
4
Date filed
7/29/2024, 05:25 PM
Previous filing
Feb 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Options Exercise $941K +9.3K +23% $101.16 49.7K Jul 25, 2024 Direct
transaction HCA Common Stock Tax liability -$1.86M -5.28K -10.61% $352.79 44.4K Jul 25, 2024 Direct
transaction HCA Common Stock Sale -$1.44M -4K -9% $360.20 40.4K Jul 29, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCA Stock Appreciation Right Options Exercise $0 -9.3K -100% $0.00* 0 Jul 25, 2024 Common Stock 9.3K $101.16 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $360.05 to $360.205, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019.